loadpatents
name:-0.040947914123535
name:-0.039770126342773
name:-0.0035030841827393
Holladay; Mark W. Patent Filings

Holladay; Mark W.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Holladay; Mark W..The latest application filed is for "raf kinase modulator compounds and methods of use thereof".

Company Profile
3.38.38
  • Holladay; Mark W. - San Diego CA
  • - San Diego CA US
  • Holladay; Mark W - San Diego CA
  • Holladay; Mark W. - Tucson AZ
  • Holladay; Mark W. - Libertyville IL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Compounds and methods for kinase modulation, and indications therefor
Grant 10,829,484 - Holladay , et al. November 10, 2
2020-11-10
RAF kinase modulator compounds and methods of use thereof
Grant 10,053,430 - Abraham , et al. August 21, 2
2018-08-21
Heterocyclic compounds and methods of use thereof
Grant 9,938,261 - Hadd , et al. April 10, 2
2018-04-10
Raf Kinase Modulator Compounds And Methods Of Use Thereof
App 20170298029 - ABRAHAM; Sunny ;   et al.
2017-10-19
RAF kinase modulator compounds and methods of use thereof
Grant 9,730,937 - Abraham , et al. August 15, 2
2017-08-15
Biaryl acetamide compounds and methods of use thereof
Grant 9,725,465 - Holladay , et al. August 8, 2
2017-08-08
Compounds And Methods For Kinase Modulation, And Indications Therefor
App 20170029413 - Holladay; Mark W. ;   et al.
2017-02-02
Heterocyclic Compounds And Methods Of Use Thereof
App 20160362405 - Hadd; Michael J. ;   et al.
2016-12-15
Heterocyclic compounds and methods of use thereof
Grant 9,452,167 - Hadd , et al. September 27, 2
2016-09-27
Raf Kinase Modulator Compounds And Methods Of Use Thereof
App 20160199375 - Abraham; Sunny ;   et al.
2016-07-14
RAF kinase modulator compounds and methods of use thereof
Grant 9,320,739 - Abraham , et al. April 26, 2
2016-04-26
JAK kinase modulating compounds and methods of use thereof
Grant 9,308,207 - Abraham , et al. April 12, 2
2016-04-12
Optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof
Grant 9,295,672 - Holladay , et al. March 29, 2
2016-03-29
Optically Active Pyrazolylaminoquinazoline, And Pharmaceutical Compositions And Methods Of Use Thereof
App 20150353528 - Holladay; Mark W. ;   et al.
2015-12-10
Raf Kinase Modulator Compounds And Methods Of Use Thereof
App 20150246042 - Abraham; Sunny ;   et al.
2015-09-03
Heterocyclic Compounds And Methods Of Use Thereof
App 20150196566 - Hadd; Michael J. ;   et al.
2015-07-16
Jak Kinase Modulating Compounds And Methods Of Use Thereof
App 20150150874 - Abraham; Sunny ;   et al.
2015-06-04
Optically Active Pyrazolylaminoquinazoline, And Pharmaceutical Compositions And Methods Of Use Thereof
App 20150141443 - HOLLADAY; Mark W. ;   et al.
2015-05-21
Biaryl Acetamide Compounds And Methods Of Use Thereof
App 20150065468 - HOLLADAY; Mark W. ;   et al.
2015-03-05
RAF kinase modulator compounds and methods of use thereof
Grant 8,969,587 - Abraham , et al. March 3, 2
2015-03-03
Heterocyclic compounds and methods of use thereof
Grant 8,952,058 - Hadd , et al. February 10, 2
2015-02-10
Optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof
Grant 8,952,020 - Holladay , et al. February 10, 2
2015-02-10
JAK kinase modulating compounds and methods of use thereof
Grant 8,927,711 - Abraham , et al. January 6, 2
2015-01-06
Optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof
Grant 8,912,324 - Holladay , et al. December 16, 2
2014-12-16
Optically Active Pyrazolylaminoquinazoline, And Pharmaceutical Compositions And Methods Of Use Thereof
App 20140194449 - HOLLADAY; Mark W. ;   et al.
2014-07-10
Optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof
Grant 8,703,943 - Holladay , et al. April 22, 2
2014-04-22
Raf Kinase Modulator Compounds And Methods Of Use Thereof
App 20140045868 - Abraham; Sunny ;   et al.
2014-02-13
Quinazoline compounds and methods of use thereof
Grant 8,633,207 - Hadd , et al. January 21, 2
2014-01-21
RAF kinase modulator compounds and methods of use thereof
Grant 8,618,289 - Abraham , et al. December 31, 2
2013-12-31
RAF kinase modulator compounds and methods of use thereof
Grant 08618289 -
2013-12-31
Thienopyridine And Thienopyrimidine Compounds And Methods Of Use Thereof
App 20130317045 - Hadd; Michael J. ;   et al.
2013-11-28
Azolopyridine And Azolopyrimidine Compounds And Methods Of Use Thereof
App 20130303533 - Chao; Qi ;   et al.
2013-11-14
Quinoline And Isoquinoline Derivatives For Use As Jak Modulators
App 20130296363 - Faraoni; Raffaella ;   et al.
2013-11-07
Jak Kinase Modulating Compounds And Methods Of Use Thereof
App 20130245014 - Abraham; Sunny ;   et al.
2013-09-19
7-cyclylquinazoline Derivatives And Methods Of Use Thereof
App 20130225578 - Hadd; Michael J. ;   et al.
2013-08-29
Heterocyclic Compounds And Methods Of Use Thereof
App 20130096113 - Hadd; Michael J. ;   et al.
2013-04-18
Biaryl Compounds And Methods Of Use Thereof
App 20130035326 - Abraham; Sunny ;   et al.
2013-02-07
JAK kinase modulating compounds and methods of use thereof
Grant 8,349,851 - Abraham , et al. January 8, 2
2013-01-08
Adenosine A3 Receptor Modulating Compounds And Methods Of Use Thereof
App 20120053176 - Armstrong; Robert C. ;   et al.
2012-03-01
Optically Active Pyrazolylaminoquinazoline, And Pharmaceutical Compositions And Methods Of Use Thereof
App 20120053194 - Holladay; Mark W. ;   et al.
2012-03-01
Optically Active Pyrazolylaminoquinazoline, And Pharmaceutical Compositions And Methods Of Use Thereof
App 20120053193 - Holladay; Mark W. ;   et al.
2012-03-01
Quinazoline Compounds And Methods Of Use Thereof
App 20120053174 - Hadd; Michael J. ;   et al.
2012-03-01
Piperazine derivatives as stearoyl-coa desaturase inhibitors and their use as therapeutic agents
Grant 8,030,488 - Sviridov , et al. October 4, 2
2011-10-04
Raf Kinase Modulator Compounds And Methods Of Use Thereof
App 20110118245 - Abraham; Sunny ;   et al.
2011-05-19
Combination therapy
Grant 7,919,484 - Kamboj , et al. April 5, 2
2011-04-05
Jak Kinase Modulating Compounds And Methods Of Use Thereof
App 20100317659 - Abraham; Sunny ;   et al.
2010-12-16
Pyridazine derivatives and their use as therapeutic agents
Grant 7,754,711 - Chakka , et al. July 13, 2
2010-07-13
Non-nucleotide compositions and method for treating pain
Grant 7,749,980 - Plourde, Jr. , et al. July 6, 2
2010-07-06
Combination Therapy
App 20090131447 - Kamboj; Rajender ;   et al.
2009-05-21
Piperazine Derivatives And Their Use As Therapeutic Agents
App 20090030008 - Sviridov; Serguei ;   et al.
2009-01-29
Piperazine derivatives and their use as therapeutic agents
Grant 7,456,180 - Sviridov , et al. November 25, 2
2008-11-25
Pyridazine derivatives and their use as therapeutic agents
Grant 7,335,658 - Chakka , et al. February 26, 2
2008-02-26
Non-nucleotide compositions and method for treating pain
App 20070123544 - Plourde; Robert JR. ;   et al.
2007-05-31
Piperazine derivatives and their use as therapeutic agents
App 20060252767 - Sviridov; Serguei ;   et al.
2006-11-09
Pyridazine derivatives and their use as therapeutic agents
App 20060009459 - Chakka; Nagasree ;   et al.
2006-01-12
Pyridazine derivatives and their use as therapeutic agents
App 20050065143 - Chakka, Nagasree ;   et al.
2005-03-24
Potassium channel openers
Grant 6,645,968 - Altenbach , et al. November 11, 2
2003-11-11
3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission
Grant 6,437,138 - Lin , et al. August 20, 2
2002-08-20
Potassium channel openers
App 20020028836 - Altenbach, Robert J. ;   et al.
2002-03-07
Potassium channel openers
App 20010036950 - Carroll, William A. ;   et al.
2001-11-01
3-Pyridyl enantiomers and their use as analgesics
Grant 6,133,253 - Holladay , et al. October 17, 2
2000-10-17
3-Pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission
Grant 6,127,386 - Lin , et al. October 3, 2
2000-10-03
3-pyridyloxymethyl heterocyclic ether compounds useful in controlling neurotransmitter release
Grant 5,948,793 - Abreo , et al. September 7, 1
1999-09-07
7A-heterocycle substituted hexahydro-1H-pyrrolizine compounds useful in controlling chemical synaptic transmission
Grant 5,733,912 - Wasicak , et al. March 31, 1
1998-03-31
3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission
Grant 5,629,325 - Lin , et al. May 13, 1
1997-05-13
2-((nitro)phenoxymethyl) heterocyclic compounds that enhance cognitive function
Grant 5,472,958 - Gunn, Jr. , et al. December 5, 1
1995-12-05
Amino acid analog CCK antagonists
Grant 5,346,907 - Kerwin, Jr. , et al. September 13, 1
1994-09-13
Peptide analog type-B CCK receptor ligands
Grant 5,340,802 - Shiosaki , et al. August 23, 1
1994-08-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed